These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 5565539)

  • 21. Criteria associated with destruction of leukemia and solid tumor cells in animals.
    Skipper HE
    Cancer Res; 1967 Dec; 27(12):2636-45. PubMed ID: 6082300
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.
    Schmid FA; Hutchison DJ
    Cancer Chemother Rep; 1972 Aug; 56(4):473-81. PubMed ID: 5081590
    [No Abstract]   [Full Text] [Related]  

  • 23. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia.
    Schmid FA; Hutchison DJ; Otter GM; Stock CC
    Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The return of antimetabolite sensitivity in methotrexate- and 6-mercaptopurine-resistant L1210 murine leukemia by the process of adaptive selection.
    Wallerstein H; Slater LM; Eng B; Calman N
    Cancer Res; 1972 Oct; 32(10):2235-40. PubMed ID: 5080766
    [No Abstract]   [Full Text] [Related]  

  • 25. Experimental evaluation of potential anticancer agents XV. On the relative rates of growth and host kill of "single" leukemia cells that survive in vivo cytoxan therapy.
    Wilcox WS; Schabel FM; Skipper HE
    Cancer Res; 1966 May; 26(5):1009-14. PubMed ID: 5934786
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunosuppressive activity of methotrexate and arabinosyl cytosine in mice bearing L1210 leukaemia.
    Baldini L; Brambilla G; Cavanna M; Parodi S
    Br J Pharmacol; 1968 Nov; 34(3):674P-676P. PubMed ID: 5726804
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.
    Dombernowsky P; Nissen NI
    Eur J Cancer (1965); 1976 Mar; 12(3):181-8. PubMed ID: 939236
    [No Abstract]   [Full Text] [Related]  

  • 28. The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.
    Woodman RJ; Sirica AE; Gang M; Kline I; Venditti JM
    Chemotherapy; 1973; 18(3):169-83. PubMed ID: 4119363
    [No Abstract]   [Full Text] [Related]  

  • 29. Rationale of chemotherapeutic adjuvant treatment.
    Goldin A
    Arch Geschwulstforsch; 1978; 48(7):627-35. PubMed ID: 736743
    [No Abstract]   [Full Text] [Related]  

  • 30. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Kline I; Woodman RJ; Gang M; Cysyk RL; Venditti JM
    Cancer Chemother Rep; 1973; 57(3):291-8. PubMed ID: 4751255
    [No Abstract]   [Full Text] [Related]  

  • 31. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of 2,2'(methylenediimino)bis-1,3,4-thiadiazole (NSC-143019) on tumor growth and immune responses in mice.
    Matsumoto T; Ootsu K; Okada Y
    Cancer Chemother Rep; 1974; 58(3):331-44. PubMed ID: 4152218
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antitumor chemotherapy. Considerations on the potential role of immunity].
    Mihich E
    Pathol Biol; 1967 Feb; 15(3):209-14. PubMed ID: 4860732
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide.
    Rose WC; Trader MW; Laster WR; Schabel FM
    Cancer Treat Rep; 1978 Sep; 62(9):1337-49. PubMed ID: 688277
    [No Abstract]   [Full Text] [Related]  

  • 35. Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210.
    Hoffman GS; Kline I; Gang M; Tyrer DD; Goldin A; Mantel N; Venditti JM
    Cancer Chemother Rep; 1969 Oct; 53(5):265-71. PubMed ID: 5377613
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice.
    Mihich E
    Cancer Res; 1969 Apr; 29(4):848-54. PubMed ID: 4887203
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].
    Savchenko VG; Parovichnikova EN; Isaev VG; Kulimova EP; Kucher RA; Sokolov AN; Ustinova EN; Gribanova EO; Khoroshko ND; Pivnik AV; Tikhonova LIu; Sarkisian GP; Domracheva EV; Maslova ER; Konstantinova TS; Rekhtman GB; Lapin VA; Miliutina TI
    Ter Arkh; 2001; 73(7):6-15. PubMed ID: 11523412
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of 4,4'-diacetyl-diphenyl-urea-bis(guanylhydrazone) on leukemia L1210.
    Mihich E; Mulhern AI
    Cancer Res; 1968 Feb; 28(2):354-62. PubMed ID: 5641525
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute leukemia treatment.
    Bernard J
    Cancer Res; 1967 Dec; 27(12):2565-9. PubMed ID: 6082296
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemotherapy of cancer. Hints for continuing medical education].
    Berndt H; Rieche K
    Z Arztl Fortbild (Jena); 1974 Feb; 68(4):193-5. PubMed ID: 4838434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.